Citizens JMP analyst Greg Miller raised the firm’s price target on GDS Holdings (GDS) to $40 from $35 and keeps an Outperform rating on the ...

Pharmaceuticals Analysts discusses Hypothalamic Obesity Grand Rounds Ahead of Rhythm’s Phase 3 Data (RYTM) on an Analyst/Industry conference ...

On Friday, JMP Securities analyst Devin Ryan maintained a Market Perform rating for Piper Sandler (NYSE: PIPR), a leading player in the middle markets. According to InvestingPro data, the $4.47 ...

Analysts at B. Riley started coverage on shares of Genius Sports (NYSE:GENI – Get Free Report) in a report released on ...

Citizens Jmp upgraded shares of Duolingo (NASDAQ:DUOL – Free Report) from a market perform rating to an outperform rating in ...

Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from ...

Artificial intelligence continues stirring things up in chemistry. To wit: YC-backed Cambridge, U.K.-based ReactWise is using ...

Analysts expect the Austin, Texas-based company to report quarterly earnings at 2 cents per share, versus a year-ago loss of ...

C3.ai’s revenue growth doesn’t mask deep losses and valuation concerns. Read why AI stock remains a Hold until clearer signs ...

Inovio plans to begin submitting the BLA for INO-3107 in mid-2025, with a goal of achieving FDA acceptance for filing by year-end 2025. Priority review will also be requested.

We recently published a list of 10 Worst High-Risk High-Reward Growth Stocks To Buy. In this article, we are going to take a ...

We recently published a list of 12 AI Stocks on Wall Street’s Radar Today. In this article, we are going to take a look at ...